Active Ingredient(s): Defibrotide Sodium
FDA Approved: * March 30, 2016
Pharm Company: * GENTIUM SRL
Category: Blood Thinner (Anticoagulant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Defitelio Overview

Defibrotide, sold under the brandname Defitelio, is a mixture of single-stranded oligonucleotides that is purified from the intestinal mucosa of pigs. It is used to treat veno-occlusive disease of the liver of people having had a bone marrow transplant, with different limitations in the US and the European Union. It works by protecting the cells lining blood vessels in the liver and preventing blood clotting; the way it does this is not well understood.[3][2]&a...

Read more Defitelio Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Defitelio Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Defibrotide Sodium
  • Injection: 200mg/2.5ml
  • Solution: 200mg/2.5ml (80mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Defitelio: (1 result)

Sorted by National Drug Code
  • 68727-800 Defitelio 80 mg/ml Intravenous Injection, Solution by Jazz Pharmaceuticals, Inc.

Other drugs which contain Defibrotide Sodium or a similar ingredient: (1 result)